%0 Journal Article
%A van den Bent, Martin J
%A Cloughesy, Timothy F
%A Ellingson, Benjamin M
%A Allen, Joshua E
%A Blackman, Samuel C
%A Kieran, Mark W
%A Tonn, Joerg C
%A Karschnia, Philipp
%A Wijnenga, Maarten
%A Pallud, Johan
%A Young, Robert J
%A Huang, Raymond Y
%A Mellinghoff, Ingo K
%A de Groot, John
%A van der Hoorn, Anouk
%A Youssef, Gilbert
%A Hervey-Jumper, Shawn L
%A Vogelbaum, Michael A
%A Chang, Susan M
%A Wen, Patrick Y
%T The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.
%J Neuro-Oncology
%V nn
%@ 1522-8517
%C Oxford
%I Oxford Univ. Press
%M DKFZ-2025-01483
%P nn
%D 2025
%Z epub
%X The RANO criteria for response to treatment in glioma make a distinction between enhancing and unenhancing tumors, which reflects assessment of a different biological process underlying the MRI findings in enhancing and non-enhancing tumors. The recent regulatory approval of tovorafenib has also considered the patients with minor responses (25
%K Minor Response (Other)
%K RANO (Other)
%K Tumor Growth rate (Other)
%K unenhancing tumors (Other)
%K volumetric (3D) assessment (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:40692474
%R 10.1093/neuonc/noaf173
%U https://inrepo02.dkfz.de/record/303036